Questions? Call 888-624-8373

HARDBACK + PDF
your price: $56.50
add to cart

HARDBACK
list:$47.95
Web:$43.16
add to cart

PDF BOOK
your price: $37.00
add to cart

PDF CHAPTERS
your price: $2.90
select

Rights & Permissions

topleft topright

Complementary and Alternative Medicine in the United States (2005)
Board on Health Promotion and Disease Prevention (HPDP)

Page
306
bottomleft bottomright
  E-mail
 Facebook
 Digg
 Stumble
 Twitter
More

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

Complementary and Alternative Medicine in the United States

Federation Staff

Dale L. Austin, MA

Interim Chief Executive Officer

Bruce A. Levy, MD, JD

Deputy Executive Vice President, Leadership Services

Lisa Robin

Assistant Vice President, Leadership and Legislative Services

Pat McCarty

Administrative Associate, Leadership Services

The Federation thanks the following consultants for their efforts in providing input to these guidelines:

David M. Eisenberg, MD – Bernard Osher Associate Professor of Medicine; Director, Division for Research and Education in Complementary and Integrative Medical Therapies, Harvard Medical School

Russell H. Greenfield, MD – Medical Director, Carolinas Integrative Health, Carolinas HealthCare System; Visiting Assistant Professor, University of Arizona College of Medicine

Kenneth R. Pelletier, PhD, MD (hc) – Chairman, American Health Association; Clinical Professor of Medicine, University of Maryland School of Medicine and University of Arizona School of Medicine

1  

Schneiderman L. Medical ethics and alternative medicine. The Scientific Review of Alternative Medicine. Spring/Summer 1998;2,(1):63-66.

2  

In 1995, the Federation established a special committee charged with developing strategies for recommendation to state medical boards for the regulation and discipline of physicians who engage in unsafe and/or deceptive health care practices. The Federation’s House of Delegates adopted the Committee’s recommendations as policy in April 1997. That same year, the Committee was charged with providing objective information to medical boards for their use in educating licensees, the public and state legislators on issues surrounding health care practices that may be potentially harmful and/or deceptive. In 2000, the Committee was charged with the development of these guidelines.

3  

NIH. General Information About CAM and the NCCAM, Publication M-42—June 2000, NCCAM Clearinghouse, Web version updated 02/21/01

4  

FSMB. Report on Professional Conduct and Ethics. HOD April 2000, Web version at www.fsmb.org, Policy Documents.

5  

AMA. Policy E 2.07: Clinical Investigation.
Page
306